Lessee, Operating Lease, Liability, to be Paid in USD of Regencell Bioscience Holdings Ltd from Q2 2024 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Regencell Bioscience Holdings Ltd quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2024 to Q2 2025.
  • Regencell Bioscience Holdings Ltd Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2025 was $574K, a 553% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Regencell Bioscience Holdings Ltd Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $574K +$486K +553% Jun 30, 2025 20-F 2025-10-31
Q2 2024 $87.9K Jun 30, 2024 20-F 2024-10-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.